Zacks Research Analysts Raise Earnings Estimates for Avantor

Avantor, Inc. (NYSE:AVTR) – Zacks Research increased their Q2 2026 earnings per share estimates for Avantor in a research note issued to investors on Tuesday, December 10th. Zacks Research analyst D. Dey now anticipates that the company will post earnings per share of $0.29 for the quarter, up from their prior forecast of $0.28. The consensus estimate for Avantor’s current full-year earnings is $0.98 per share.

AVTR has been the subject of several other research reports. Royal Bank of Canada reissued an “outperform” rating and issued a $34.00 price target on shares of Avantor in a report on Thursday, September 26th. UBS Group cut their price target on shares of Avantor from $30.00 to $29.00 and set a “buy” rating on the stock in a report on Tuesday, October 8th. Robert W. Baird lowered their price target on shares of Avantor from $27.00 to $26.00 and set an “outperform” rating on the stock in a report on Monday, October 28th. Barclays decreased their price objective on Avantor from $28.00 to $25.00 and set an “overweight” rating for the company in a report on Friday, October 25th. Finally, Wells Fargo & Company dropped their target price on Avantor from $30.00 to $28.00 and set an “overweight” rating on the stock in a report on Monday, October 28th. Three equities research analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $27.69.

Avantor Stock Performance

Shares of Avantor stock opened at $22.53 on Friday. The company has a 50-day simple moving average of $22.53 and a two-hundred day simple moving average of $23.54. The company has a debt-to-equity ratio of 0.84, a quick ratio of 1.06 and a current ratio of 1.54. Avantor has a one year low of $19.59 and a one year high of $28.00. The company has a market capitalization of $15.33 billion, a PE ratio of 48.98, a P/E/G ratio of 2.59 and a beta of 1.29.

Hedge Funds Weigh In On Avantor

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Cetera Advisors LLC purchased a new stake in shares of Avantor in the 1st quarter valued at approximately $249,000. SG Americas Securities LLC increased its stake in Avantor by 222.0% during the second quarter. SG Americas Securities LLC now owns 19,996 shares of the company’s stock worth $424,000 after acquiring an additional 13,786 shares during the last quarter. Wealth Enhancement Advisory Services LLC increased its stake in Avantor by 2.8% during the second quarter. Wealth Enhancement Advisory Services LLC now owns 26,921 shares of the company’s stock worth $571,000 after acquiring an additional 733 shares during the last quarter. ORG Partners LLC lifted its stake in shares of Avantor by 5,773.0% in the 2nd quarter. ORG Partners LLC now owns 5,873 shares of the company’s stock valued at $122,000 after purchasing an additional 5,773 shares during the last quarter. Finally, Swedbank AB lifted its stake in shares of Avantor by 1.3% in the 2nd quarter. Swedbank AB now owns 107,182 shares of the company’s stock valued at $2,272,000 after purchasing an additional 1,327 shares during the last quarter. Institutional investors and hedge funds own 95.08% of the company’s stock.

Avantor Company Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.